Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists.
Reinforcing its dedication to providing streamlined genomic workflow solutions, the company will award up to eight grants in 2022. The grants will consist of $3,000 USD (or local currency equivalent) in genomics catalog products from Beckman Coulter Life Sciences. Applications will be accepted until 15 December 2022.
Grant program research areas include nucleic acid extraction, liquid biopsy, long-read sequencing, and genomics applications. Winners will be evaluated based on criteria that include research objective, genomic reagent request, and how the product would be used in the field of research.
Amy Yoder, Director of Genomics Product Management at Beckman Coulter Life Sciences, said: “These grants represent just part of how we continuously invest in the scientific community at every level to fuel creativity that can lead to advancements. We’re proud to be a part of the journey of researchers and are eager to review submissions.”
To apply and for a complete list of rules, visit https://www.beckman.com/reagents/genomic/collaboration-grant-program/spri-grants.
The grant program has allowed previous winners to research a novel cystic fibrosis treatment, new cancer molecular diagnostic tools, and novel models to study diabetes and metabolism.
